Sharon E. Byrd

2.3k total citations
82 papers, 1.6k citations indexed

About

Sharon E. Byrd is a scholar working on Pediatrics, Perinatology and Child Health, Surgery and Genetics. According to data from OpenAlex, Sharon E. Byrd has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pediatrics, Perinatology and Child Health, 23 papers in Surgery and 15 papers in Genetics. Recurrent topics in Sharon E. Byrd's work include Fetal and Pediatric Neurological Disorders (19 papers), Glioma Diagnosis and Treatment (12 papers) and Neonatal and fetal brain pathology (10 papers). Sharon E. Byrd is often cited by papers focused on Fetal and Pediatric Neurological Disorders (19 papers), Glioma Diagnosis and Treatment (12 papers) and Neonatal and fetal brain pathology (10 papers). Sharon E. Byrd collaborates with scholars based in United States, Canada and United Kingdom. Sharon E. Byrd's co-authors include Crystal F. Darling, George E. Locke, Thomas P. Naidich, Tadanori Tomita, Mary Ann Radkowski, Robin E. Osborn, David G. McLone, Timothy P. Bohan, L. D. Kramer and Charles R. Fitz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Cancer.

In The Last Decade

Sharon E. Byrd

78 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon E. Byrd United States 25 483 329 321 242 226 82 1.6k
R. N. Şener Türkiye 24 496 1.0× 471 1.4× 180 0.6× 384 1.6× 298 1.3× 184 2.2k
R M Quencer United States 24 667 1.4× 126 0.4× 380 1.2× 294 1.2× 268 1.2× 55 1.4k
John C. Stears United States 22 358 0.7× 175 0.5× 213 0.7× 272 1.1× 209 0.9× 41 1.5k
Taher El Gammal United States 26 609 1.3× 189 0.6× 145 0.5× 412 1.7× 383 1.7× 78 1.9k
G. Kalifa France 27 748 1.5× 500 1.5× 214 0.7× 131 0.5× 125 0.6× 124 2.6k
Gary L. Hedlund United States 26 725 1.5× 490 1.5× 154 0.5× 305 1.3× 167 0.7× 70 2.1k
Avery H. Weiss United States 27 501 1.0× 285 0.9× 171 0.5× 236 1.0× 110 0.5× 91 2.6k
D. K. Chhabra India 21 668 1.4× 126 0.4× 300 0.9× 235 1.0× 188 0.8× 51 1.2k
Simon J. Wheeler United Kingdom 24 460 1.0× 189 0.6× 265 0.8× 122 0.5× 144 0.6× 54 1.5k
Mathew J. Chandy India 28 1.1k 2.2× 143 0.4× 415 1.3× 351 1.5× 340 1.5× 88 2.1k

Countries citing papers authored by Sharon E. Byrd

Since Specialization
Citations

This map shows the geographic impact of Sharon E. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon E. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon E. Byrd more than expected).

Fields of papers citing papers by Sharon E. Byrd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon E. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon E. Byrd. The network helps show where Sharon E. Byrd may publish in the future.

Co-authorship network of co-authors of Sharon E. Byrd

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon E. Byrd. A scholar is included among the top collaborators of Sharon E. Byrd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon E. Byrd. Sharon E. Byrd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koçak, Mehmet, et al.. (2024). Fetal MRI Analysis of Corpus Callosal Abnormalities: Classification, and Associated Anomalies. Diagnostics. 14(4). 430–430.
2.
Supanich, Mark, et al.. (2023). Review of deep learning and artificial intelligence models in fetal brain magnetic resonance imaging. World Journal of Clinical Cases. 11(16). 3725–3735. 10 indexed citations
3.
Supanich, Mark, et al.. (2023). Automatic Ventriculomegaly Detection in Fetal Brain MRI: A Step-by-Step Deep Learning Model for Novel 2D-3D Linear Measurements. Diagnostics. 13(14). 2355–2355. 7 indexed citations
4.
Tan, Lee A., et al.. (2014). Magnetic resonance imaging characteristics of typical and atypical/anaplastic meningiomas – Case series and literature review. British Journal of Neurosurgery. 29(1). 77–81. 9 indexed citations
5.
Shors, Stephanie M., et al.. (2012). MRI. Clinical Obstetrics & Gynecology. 55(1). 352–366. 19 indexed citations
6.
Nyenhuis, David L., Laura Pedelty, Sharon E. Byrd, et al.. (2008). Baseline differences between vascular cognitive impairment no dementia reverters and non-reverters. Journal of Neurology Neurosurgery & Psychiatry. 79(11). 1208–1217. 13 indexed citations
7.
Pang, Dachling, et al.. (2000). A 14-Year-Old Young Woman with a Five-Week History of Back Pain. Pediatric Neurosurgery. 32(2). 100–108. 8 indexed citations
8.
Norfray, Joseph F., Crystal F. Darling, Sharon E. Byrd, et al.. (1999). Short TE Proton MRS and Neurofibromatosis Type 1 Intracranial Lesions. Journal of Computer Assisted Tomography. 23(6). 994–1003. 15 indexed citations
9.
Tomita, Tetsuya, et al.. (1999). Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors.. American Journal of Roentgenology. 173(1). 119–125. 29 indexed citations
10.
Byrd, Sharon E., et al.. (1997). MR imaging of symptomatic neurocutaneous melanosis in children. Pediatric Radiology. 27(1). 39–44. 42 indexed citations
11.
Rosenfeld, Elaine, Sharon E. Byrd, & Stanford T. Shulman. (1996). Neurocysticercosis Among Children in Chicago. Clinical Infectious Diseases. 23(2). 262–268. 58 indexed citations
12.
Byrd, Sharon E., Crystal F. Darling, & Elisa Allen. (1994). CONTRAST AGENTS IN NEUROIMAGING. Neuroimaging Clinics of North America. 4(1). 9–26. 2 indexed citations
13.
Ball, William S., S N Nadel, R A Zimmerman, et al.. (1993). Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease.. Radiology. 186(3). 769–774. 19 indexed citations
14.
Gelber, R H, et al.. (1992). A clinical trial of minocycline in lepromatous leprosy.. BMJ. 304(6819). 91–92. 42 indexed citations
15.
Byrd, Sharon E., Robin E. Osborn, & Mary Ann Radkowski. (1991). The MR evaluation of pachygyria and associated syndromes. European Journal of Radiology. 12(1). 53–59. 5 indexed citations
16.
Byrd, Sharon E. & R H Gelber. (1991). Effect of dapsone on haemoglobin concentration in patients with leprosy. Leprosy Review. 62(2). 171–8. 30 indexed citations
17.
Byrd, Sharon E., et al.. (1991). Magnetic Resonance Imaging in Infants Exposed to Cocaine Prenatally: A Preliminary Report. Clinical Pediatrics. 30(8). 506–508. 10 indexed citations
18.
Byrd, Sharon E., Robin E. Osborn, Timothy P. Bohan, & Thomas P. Naidich. (1989). The CT and MR evaluation of migrational disorders of the brain. Pediatric Radiology. 19(3). 151–156. 35 indexed citations
19.
Radkowski, Mary Ann, Thomas P. Naidich, Tadanori Tomita, Sharon E. Byrd, & David G. McLone. (1988). Neonatal Brain Tumors. Journal of Computer Assisted Tomography. 12(1). 10–20. 44 indexed citations
20.
Fitz, Charles R., et al.. (1977). Pediatric myelography with metrizamide.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 355. 182–92. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026